Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
50%
Total
Publications
4.9K
Total Open
Publications
2.5K
Total
Citations
143K
Open Access
Percentage
50%
Total
Publications
4.9K
Total Open
Publications
2.5K
Total
Citations
143K
Breakdown
Publisher Open
26%
Both
21%
Other Platform Open
3%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
686
Hybrid 41%
937
No Guarantees 29%
675
Other Platform Open
Domain 79%
964
Institution 21%
254
Other Internet 18%
216
Public 3%
42
Preprint 0%
2
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 965 |
DOI | Other Internet | 166 |
Europe PMC | Domain | 72 |
Unknown Repository | Other Internet | 54 |
DANS - Data Archiving and Networked Services | Institution | 54 |
Figshare | Public | 40 |
Digital Access to Libraries | Institution | 26 |
Elsevier - Scopus | Institution | 14 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 11 |
Yonsei University Medical Library - YUHSpace | Institution | 9 |